4/A: Genelux Corp Director Amends Stock Option Filing Due to Error

A Genelux Corp director amended a previous filing to correct the exercise price of a stock option grant.

Summary

• A Form 4/A filing was submitted by John W. Smither, a director at Genelux Corp, to amend a previous filing.
• The amendment corrects the exercise price of a stock option granted on August 1, 2024.
• The original filing incorrectly stated the exercise price as $1.54 per share.
• The corrected exercise price is $1.96 per share.
• The stock option grants the right to buy 50,469 shares of common stock.
• The options vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders.
• The options expire on July 31, 2034.

Sentiment

Score: 7

Explanation: The document is a routine correction of a filing error, which is neutral to slightly positive as it shows attention to detail.

Industry Context

This is a standard regulatory filing related to stock options granted to a company director, which is common practice in publicly traded companies.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies as part of their compensation packages.
• The vesting schedule of one year or the next annual meeting is a typical vesting structure.
• The 10-year expiration period is also within the standard range for stock options.

Stakeholder Impact

• The correction of the stock option price ensures transparency for shareholders.

Key Dates

Keywords

stock option, amendment, director, Genelux Corp, Form 4, beneficial ownership, exercise price